2 December 2020
1300 794 893
Subscribe

Why are more people becoming sensitive to gluten?

28 March 2020

More videos

Have the Beijing bad boys turned Treasury Wine Estates and a2 milk into screaming buys?!

On this week's investing show, Peter Switzer is joined by Julia Lee from Burman Invest, Rudi Filapek-VanDyck from FNArena, Jun Bei Liu from Tribeca Investment Partners and Paul Rickard.

New COVID-19 evidence

Dr Ross Walker talks about new evidence of the coronavirus, its fatality rates and possible mutations.

Why Joe Biden will be good for Australian house prices

On this week's show, Peter Switzer is joined by Wealthi's Peter Esho and Real Estate Institute of NSW's Tim McKibben.

Is ScoMo starting to suck up to the Beijing bad boys & what 2 stocks could benefit?

Join Peter Switzer and Paul Rickard for the latest episode of Mad about Money.

Why is Mesoblast blasting higher again & 3 new stocks that are hot!

On this week's show, Peter Switzer speaks to Shaw and Partners' Adam Dawes, Burman Invest's Julia Lee, AMP Capital's Shane Oliver, Switzer's Paul Rickard and nabtrade's Gemma Dale.

The Oxford COVID-19 vaccine trial

Dr Ross Walker looks at the differences between the Oxford and Pfizer vaccine trials and shares the promising results from both.

Is the property price rebound continuing & what suburbs/towns are hot?

This week, Peter Switzer speaks to REA Group's Nerida Conisbee, Century 21's Charles Tarbey and buyers agent Michelle May.

Marie Brownell & Jodi Kennedy from Equity Trustees (ASX:EQT)

Peter Switzer is joined by Marie Brownell (National Manager, Estate Planning) & Jodi Kennedy (General Manager, Charitable Trusts and Philanthropy) from Equity Trustees (ASX:EQT).

Mad about Money Live

Tune in to hear Peter Switzer and Paul Rickard discuss the latest money news and how it affects you.

Hearts & Minds Conference: Which 4 stocks are the Top 4 Fund Managers Buying!

Julia Lee, Michael Gable, Jun Bei Liu, Paul Rickard and Peter Schiff speak to Peter Switzer.

Christopher Hulls from Life360 (ASX:360)

Peter Switzer speaks to the CEO of Life360 (ASX:360), Christopher Hulls.

The Pfizer COVID-19 vaccine

Dr Ross Walker looks at the recent findings from the Pfizer vaccine trial.

1 2 3 40
Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
1300 794 893
© 2006-2020 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
homephoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram